Teva Pharmaceutical Industries (TEVA) Depreciation & Amortization (CF) (2009 - 2026)
Teva Pharmaceutical Industries (TEVA) posted Depreciation & Amortization (CF) of $241 million for Q2 2026, down 4.0% from $251 million a year earlier but up 0.8% from the prior quarter.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Teva Pharmaceutical Industries was $989 million, down 3.3% year-over-year; for FY2025, it was $1 billion, down 5.4% from FY2024.
- Annual Depreciation & Amortization (CF) has declined for eight consecutive years, with a five-year compound annual growth rate of -8.4% (FY2020 to FY2025).
- In prior years, Teva Pharmaceutical Industries' Depreciation & Amortization (CF) was $1.06 billion in FY2024 (-8.2%), $1.15 billion in FY2023 (-11.9%), $1.31 billion in FY2022 (-1.7%) and $1.33 billion in FY2021 (-14.6%).
- Quarterly Depreciation & Amortization (CF) has run from a low of $239 million in Q1 2026 to a high of $358 million in Q2 2022 over five years.
- On a year-over-year basis, Depreciation & Amortization (CF) has declined in each of the last six quarters, with an average decline of 4.2% over the last eight quarters.
- The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q2 2022, with growth of 17.4%; the weakest was Q4 2021, with a decline of 19.0%.
- According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $239 million (Q1 2026), $260 million (Q4 2025) and $249 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.96 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 194.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 599.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.93 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 98.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.62 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 56.50 Mn |
| 10 | Teva Pharmaceutical Industries | 46.10 Bn | 32.95 Bn | 2.15 Bn | 241.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 241.00 Mn |
| Mar 31, 2026 | 239.00 Mn |
| Dec 31, 2025 | 260.00 Mn |
| Sep 30, 2025 | 249.00 Mn |
| Jun 30, 2025 | 251.00 Mn |
| Mar 31, 2025 | 244.00 Mn |
| Dec 31, 2024 | 269.00 Mn |
| Sep 30, 2024 | 259.00 Mn |
| Jun 30, 2024 | 259.00 Mn |
| Mar 31, 2024 | 272.00 Mn |
| Dec 31, 2023 | 266.00 Mn |
| Sep 30, 2023 | 283.00 Mn |
| Jun 30, 2023 | 300.00 Mn |
| Mar 31, 2023 | 304.00 Mn |
| Dec 31, 2022 | 306.00 Mn |
| Sep 30, 2022 | 321.00 Mn |
| Jun 30, 2022 | 358.00 Mn |
| Mar 31, 2022 | 323.00 Mn |
| Dec 31, 2021 | 320.00 Mn |
| Sep 30, 2021 | 329.00 Mn |
API Access
Teva Pharmaceutical Industries Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=TEVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();